This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
GlaxoSmithKline Pakistan Limited
GlaxoSmithKline Pakistan Limited, commonly referred to as GSK Pakistan, is a leading healthcare company headquartered in Karachi, Pakistan. Established in 1947, GSK Pakistan has made significant strides in the pharmaceutical and consumer healthcare sectors, focusing on innovative medicines, vaccines, and consumer health products. With a strong presence across major regions in Pakistan, GSK Pakistan is renowned for its commitment to improving health outcomes through its diverse portfolio, which includes prescription medications, over-the-counter products, and vaccines. The company is particularly noted for its advancements in respiratory and infectious disease treatments. As a subsidiary of GlaxoSmithKline plc, GSK Pakistan has achieved notable market recognition, consistently ranking among the top pharmaceutical companies in the country, driven by its dedication to research and development and a robust distribution network.
DitchCarbon Score
How does GlaxoSmithKline Pakistan Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
GlaxoSmithKline Pakistan Limited's score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
GlaxoSmithKline Pakistan Limited, headquartered in PK, currently does not report specific carbon emissions data, as no emissions figures are available. The company is a current subsidiary of GSK plc, which influences its climate commitments and initiatives. GSK plc has set ambitious climate targets, including commitments to reduce emissions across its operations. These targets are cascaded to GlaxoSmithKline Pakistan Limited, aligning with the Science Based Targets initiative (SBTi) and other sustainability frameworks. The company is actively involved in initiatives such as RE100, which aims for 100% renewable electricity, and the Climate Pledge, which focuses on achieving net-zero emissions. While specific reduction targets for GlaxoSmithKline Pakistan Limited are not detailed, the overarching goals from GSK plc indicate a strong commitment to sustainability and reducing carbon footprints across its global operations.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 851,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 745,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 16,093,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
GlaxoSmithKline Pakistan Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
